CXCR3 and glioblastoma: Identifying the function of CXCR3 will better instruct the use of immunotherapies to treat glioblastoma via augmenting CXCR3 expression on CAR T cells infused via the CSF to improve entry to the brain, or improve T cell-DC interactions to enhance anti-tumour responses when paired with ICI therapy.